FORTIS LIFE SCIENCES Profile

Fortis Life Sciences is a strategic platform providing capital, expertise, and operational resources enabling the growth and success of founder-led life sciences tools companies.

Fortis Life Sciences was founded in 2020, with the vision of creating an exceptional life sciences company focused on offering world class products coupled with a best-in-class customer experience.

What Bethyl Laboratories offers:

Our scientists oversee the entire antibody production lifecycle, with a sole focus on quality. We use a unique validation and quality control protocol to select for antibodies with the highest sensitivity and minimal cross reactivity. Instead of testing one antibody, we test with paired antibodies raised against distinct protein epitopes. Only antibodies that demonstrate specificity by immunoprecipitation and/or Western blot are advanced for testing in other applications.

• Primary antibodies for basic and translational research
  • Polyclonal: over 9,500 catalog products; offering over 8,200 primary antibodies targeting over 3,300 proteins
  • Recombinant and monoclonal: 120+ products
• Primary antibodies supplied as analyte specific reagents for use in IVD, as well as epitope tag antibodies
• 1,300 secondary antibodies against 25+ species
• Purified proteins, calibrators and controls ELISA kits
• Contract recombinant antibody service supporting bio-pharma
• Custom polyclonal antibody production